iSpecimen Inc. Files 8-K Report

TL;DR

iSpecimen filed an 8-K on Dec 13, 2024, covering other events and financial exhibits.

AI Summary

On December 13, 2024, iSpecimen Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and operational events. Specific details regarding the nature of these events or financial statements are not elaborated in the provided text.

Why It Matters

This 8-K filing signals that iSpecimen Inc. has made significant disclosures to the SEC, which could impact investors' understanding of the company's current status and future prospects.

Risk Assessment

Risk Level: low — The filing is a standard 8-K report without immediate negative or positive financial implications detailed in the provided text.

Key Players & Entities

• iSpecimen Inc. (company) — Registrant
• December 13, 2024 (date) — Date of earliest event reported
• 001-40501 (other) — Commission File Number
• 27-0480143 (other) — IRS Employer Identification No.
• 8 Cabot Road, Suite 1800 Woburn, MA 01801 (address) — Principal executive offices
• 781-301-6700 (phone_number) — Registrant's telephone number

FAQ

From the Filing

0001104659-24-128411.txt : 20241213 0001104659-24-128411.hdr.sgml : 20241213 20241213160124 ACCESSION NUMBER: 0001104659-24-128411 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20241213 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241213 DATE AS OF CHANGE: 20241213 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iSpecimen Inc. CENTRAL INDEX KEY: 0001558569 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 270480143 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40501 FILM NUMBER: 241548261 BUSINESS ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 BUSINESS PHONE: 781-301-6700 MAIL ADDRESS: STREET 1: 8 CABOT ROAD STREET 2: SUITE 1800 CITY: WOBURN STATE: MA ZIP: 08101 8-K 1 tm2430993d1_8k.htm FORM 8-K false 0001558569 0001558569 2024-12-13 2024-12-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares       UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM  8-K   CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934   Date of Report (Date of earliest event reported): December 13, 2024   iSpecimen Inc. (Exact name of registrant as specified in its charter)   Delaware   001-40501   27-0480143 (State or other jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   8 Cabot Road, Suite 1800 Woburn , MA 01801 (Address of principal executive offices, including zip code)   Registrant’s telephone number, including area code: ( 781 ) 301-6700   Not Applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading symbol(s)   Name of each exchange on which registered Common Stock, par value $0.0001 per share   ISPC   The Nasdaq Stock Market LLC   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨             Item 8.01 Other Events.   On December 13, 2024, iSpecimen Inc. (the “Company”) announced positive results attributed to its Next Day Quote Program (“NDQ”), a next-day quote service for researchers and providers designed to accelerate the biospecimen transaction process. The NDQ program delivers accurate biospecimen sample pricing within 24 hours of receiving customer requests.   A copy of the press release is furnished as Exhibit 99.1 t